The Business Research Company’s report on the Cell & Gene Therapy Manufacturing Services Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the cell & gene therapy manufacturing services market further?
The high incidence of cancer and other target diseases is expected to propel the growth of the cell and gene therapy manufacturing services market going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. Cell and gene therapies are developing as promising new strategies to combat the rising incidence of cancer, which is driving the demand for novel and efficient treatment choices. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. Therefore, the high incidence of cancer and other target diseases is driving the growth of the cell and gene therapy manufacturing services market going forward.
Access Your Free Sample of the Global Cell & Gene Therapy Manufacturing Services Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
What are the key factors influencing the forecasted market size of the cell & gene therapy manufacturing services industry?
The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from$8.15 billion in 2024 to $9.46 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increased R&D investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine
The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to “$17.97 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Who are the leading competitors in the cell & gene therapy manufacturing services market?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE
Which emerging trends are set to transform the cell & gene therapy manufacturing services market landscape?
Technological advancements are a key trend gaining popularity in the cell and gene therapy manufacturing services market. Major companies operating in the cell and gene therapy manufacturing services market are adopting new technologies to sustain their position in the market. For instance, in October 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing in various preclinical and clinical laboratory, gene therapy, and cell therapy services, launched the navigation Vector Platform (navigation). It is a platform that simplifies the path to GMP Adeno-Associated Virus (AAV) vector manufacturing without requiring extensive process development. Compared to standard manufacturing workflows, the navigation platform can cut a program’s timeframe to GMP by 55% for viral vector gene therapy researchers. Charles River’s navigation technique is based on a unique high-productivity HEK293 suspension cell line that can be scaled up and serotyped to meet clients’ needs.
How do different geographies compare in terms of market share and growth potential in the cell & gene therapy manufacturing services market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
Which major segments of the cell & gene therapy manufacturing services market are experiencing the fastest growth?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035
How is the cell & gene therapy manufacturing services market defined, and what are its core characteristics?
Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
